Isolation and Characterization of 2′-Fluoro-, 2′-Amino-, and 2′-Fluoro-/Amino-Modified RNA Ligands to Human IFN-γ That Inhibit Receptor Binding

Journal of Immunology

Volumn 159, Issue 1, 1997, Pages 259-267

  Kubik, Mark F ^a   Bell, Carol ^a   Fitzwater, Tim ^a   Watson, Susan R ^a   Tasset, Diane M ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON RECEPTOR; INTERFERON RECEPTOR; LIGAND; OLIGONUCLEOTIDE; PEPTIDE LIBRARY; RNA;

ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; DRUG ANTAGONISM; GENE LIBRARY; GENETICS; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; T LYMPHOCYTE;

BASE SEQUENCE; GENE LIBRARY; HUMANS; IMMUNITY, CELLULAR; LIGANDS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; PEPTIDE LIBRARY; RECEPTORS, INTERFERON; RNA; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0031183804     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Trinchieri, G., and B. Perussia. 1985. Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol. Today 6:131.
2. Wheelock, E. F. 1965. Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science 149:310.
3. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11:571.
4. Vilcek, J., P. W. Gray, E. Rinderknecht, and C. G. Sevastopoulos. 1985. Interferon γ: a lymphokine for all seasons. Lymphokines 11:1.
5. Schreiber, R. D., and A. Celada. 1985. Molecular characterization of interferon γ as a macrophage activating factor. Lymphokines 11:87.
6. Bancroft, G. J., R. D. Schreiber, C. G. Bosma, M. J. Bosma, and E. R. Unanue. 1987. A T cell-independent mechanism of macrophage activation by interferon-γ, J. Immunol. 139:1104.
7. Finkelman, F. D., J. Holmes, I. M. Katona, J. F. Urban Jr., M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. J. Immunol. 140:1022.
8. Erbe, D. V., J. E. Collins, L. Shen, R. F. Graziano, and M. W. Fanger. 1990. The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells. Mol. Immunol. 27:57.
9. Dustin, M. L., R. Rothlein, A. K. Bhan, C. A. Dinarello, and T. A. Springer, 1986. Induction by IL-1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol 137:245.
10. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241.
11. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
12. + T cells. Annu. Rev. Immunol. 12:635.
13. Pober, J. S., M. A. Gimbrone Jr., L. A. Lapierre, D. L. Mendrick, W. Fiers, R. Rothlein, and T. A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferons. J. Immunol. 137:1893.
14. Thornhill, M. H., S. M. Wellicome, D. L. Mahiouz, J. S. S. Lanchbury, U. Kyan-Aung, and D. O. Haskard. 1991. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells. J. Immunol. 146:592.
15. Munro, J. M., J. S. Pober, and R. S. Cotran. 1989. Tumor necrosis factor and interferon-γ induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio Anubis. Am. J. Pathol. 135:121.
16. Steinman, L. 1993. Autoimmune disease. Sci. Am. 269:107.
17. Powrie, F., and R. L. Coffman. 1993. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today 270:270.
18. Feldmann, M. 1989. Molecular mechanisms involved in human autoimmune diseases: relevance of chronic antigen presentation: class II expression and cytokinc production. Immunol. Suppl. 2:66.
19. Rapoport, M. J., A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Serreze, E. H. Leiter, P. Cyopick, J. S. Danska, and T. L. Delovitch. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178:87.
20. Gu, D., L. Wogensen, N. A. Calcutt, C. Xia, S. Zhu, J. P. Merlie, H. S. Fox, J. Lindstron, H. C. Powell, and N. Sarvetnick. 1995. Myasthenia gravis-like syndrome induced by expression of interferon γ in the neuromuscular junction. J. Exp. Med. 181:547.
21. Kuhn, K., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263.
22. Kuchroo, V. K., C. A. Martin, J. M. Greer, S.-T. Ju, R. A. Sobel, and M. E. Dorf. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:4371.
23. Simon, A. K., E. Seipelt, and J. Sieper. 1994. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc. Natl. Acad. Sci. USA 91:8562.
24. Traugott, U., and P. Lebon. 1988. Interferon-γ and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions. J. Neurol. Sci. 84:257.
25. Gold, L. 1995. Oligonucleotides as research, diagnostic, and therapeutic agents. J. Biol. Chem. 270:13581.
26. Gold, L., B. Polisky, O. Uhlenbeck, and M. Yarus. 1995. Diversity of oligonucleotide functions. Annu. Rev. Biochem. 64:763.
27. Pieken, W. A., D. B. Olsen, F. Benseler, H. Aurup, and F. Eckstein. 1991. Kinetic characterization of ribonuclease-resistant 2′-modified hammerhead ribozymes. Science 253:314.
28. Heidenreich, O., and F. Eckstein. 1992. Hammerhead ribozyme-mediated cleavage of the long terminal repeat of RNA of human immunodeficiency virus type 1. J. Biol. Chem. 267:1904.
29. Lin, Y., Q. Qiu, S. C. Gill, and S. D. Jayasena. 1994. Modified RNA sequence pools for in vitro selection. Nucleic Acids Res. 22:5229.
30. Green, L. S., D. Jellinek, C. Bell, L. A. Beebe, B. D. Feistner, S. C. Gill, F. M. Jucker, and N. Janjic. 1995. Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. Chem. Biol. 2:683.
31. Jellinek, D., L. S. Green, C. Bell, C. K. Lynott, N. Gill, C. Vargeese, G. Kirschenheuter, D. P. C. McGee, P. Abesinghe, W. A. Pieken, R. Shapiro, D. B. Rifkin, D. Moscatelli, and N. Janjic. 1995. Potent 2′-amino-2′-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry 34:11363.
32. McGee, D. P. C., C. Vargeese, Y. Zhai, G. P. Kirschenheuter, A. Settle, C. R. Siedem, and W. A. Pieken. 1995. Efficient synthesis of 2′-amino-2′-deoxypyrimidine 5′-triphosphates. Nucleosides Nucleotides 14:1329.
33. Tuerk, C., and L. Gold. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505.
34. Schneider, D., C. Tuerk, and L. Gold. 1992. Selection of high affinity RNA ligands to the bacteriophage R17 coat protein. J. Mol. Biol. 228:862.
35. Fitzwater, T., and B. Polisky. 1996. A SELEX primer. Methods Enzymol. 267: 275.
36. Davanloo, P., A. H. Rosenberg, J. J. Dunn, and F. W. Studier. 1984. Cloning and expression of the gene for bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci USA 81:2035.
37. Jellinek, D., C. K. Lynott, D. B Rifkin, and N. Janjic. 1993. High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc. Natl. Acad. Sci. USA 90:11227.
38. Adams, S. M., and R. Blukcsley. 1991. Linear amplification DNA sequencing. Focus 13:56.
39. Zucker, M. 1989. On finding all suboptimal foldings of an RNA molecule. Science 244:48.
40. Davis, J. P., N. Janjic, D. Pribnow, and D. A. Zichi. 1995. Alignment editing and identification of consensus secondary structures for nucleic acid sequences: interactive use of dot matrix representations. Nucleic Acids Res. 23:4471.
41. Luk, S. K-S., E. Jay, and F. T. Jay. 1990. Structure-function analysis of the human interferon γ. J. Biol. Chem. 265:13314.
42. 125I-interferon γ to receptors on human cells. J. Biol. Chem. 260:1191.
43. Ramanathan, M., M. Lantz, R. D. MacGregor, M. R. Garovoy, and C. A. Hunt. 1994. Characterization of the oligodeoxynucleotide-mediated inhibition of inter- feron-γ-induced major histocompatibility complex class I and intercellular adhesion molecule-1. J. Biol. Chem. 269:24564.
44. Kubik, M. P., A. W. Stephens, D. Schneider, R. A. Marlar, and D. Tasset. 1994. High-affinity RNA ligands to human α-thrombin. Nucleic Acids Res. 22:2619.
45. Wiegand, T. W., P. B. Williams, S. C. Dreskin, M.-H. Jouvin, J.-P. Kinet, and D. Tasset. 1996. High-affinity oligonucleotide ligands to human IgE inhibit binding to Fe receptor I. J. Immunol. 157:221.
46. Milligan, J. P., D. R. Groebe, G. W. Witherell, and O. C. Uhlenbeck. 1987. Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res. 15:8783.
47. Aurup, H., D. M. Williams, and F. Eckstein. 1992. 2′-fluoro- and 2′-amino-2′-deoxynucleoside 5′-triphosphates as substrates for T7 RNA polymerase. Biochemistry 31:9636.
48. Guschlbauer, W., and K. Jankowski. 1980. Nuclcoside conformation is determined by the electronegativity of the sugar substituent. Nucleic Acids Res. 8:1421.
49. Eaton, B. E., and W. A. Pieken. 1993. Ribonucleosides and RNA. Annu. Rev. Biochem. 64:837.
50. Rinderknecht, E., B. H. O'Connor, and H. Rodrigucz. 1984. Natural humun interferon-γ. J. Biol. Chem. 259:6790.
51. Kelker, H. C., Y. K. Yip, P. Anderson, and J. Vilcek. 1983. Effects of glycosidase treatment on the physiochemical properties and biological activity of humun interferon-γ. J. Biol. Chem. 258:8010.
52. Gray, P. W., D. W. Leung, D. Pennica, E. Yelverton, R. Najarian, C. C. Simonsen, R. Derynck, P. J. Sherwood, D. M. Wallace, S. L. Berger, A. D. Levinson, and D. V. Goeddel. 1982. Expression of human immune Interferon cDNA in E. coli and monkey cells. Nature 295:503.
53. Ealick, S. E., W. J. Cook, S. Vijay-Kumar, M. Carson, T. L. Nugubhushan, P. P. Trotta, and C. E. Bugg. 1991. Three-dimensional structure of recumbinant human IFN-γ. Science 252:698.
54. 15N NMR backbond assignments and secondary structure of human IFN-γ. Biochemistry 31:8180.
55. 125I-human interferon-γ to high affinity receptors and humun fibroblasts. J. Biol. Chem. 257: 1301.
56. Dijkmans, R., and A. Billiau. 1988. Interferon γ: a master key in the immune system. Curr. Opin. Immunol. 1:269.